BeneHold CHG transparent film dressing from Avery Dennison Medical Solutions receives 510(k) clearance


Intravenous products: Infection Control Today report “Avery Dennison Medical Solutions, a business unit of Avery Dennison Corporation, announces that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its new chlorhexidine gluconate (CHG) transparent film dressing, known as BeneHoldâ„¢ CHG Transparent Film Dressing. In-vitro test data demonstrate the new dressing’s antimicrobial efficacy across a broad range of bacteria and yeast commonly found in catheter-related bloodstream infections.

Tests show that the dressing is appropriate for applications where the spread of infection is a concern and moisture management is required, such as the securement of IV catheters. The patent-pending CHG adhesive formulation used on the dressing is transparent to allow visualization of the access site—a critical parameter for vascular access professionals.”

Click here for the full story.

Main page


Comments are closed.